ES2059467T3 - Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos. - Google Patents

Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos.

Info

Publication number
ES2059467T3
ES2059467T3 ES88117304T ES88117304T ES2059467T3 ES 2059467 T3 ES2059467 T3 ES 2059467T3 ES 88117304 T ES88117304 T ES 88117304T ES 88117304 T ES88117304 T ES 88117304T ES 2059467 T3 ES2059467 T3 ES 2059467T3
Authority
ES
Spain
Prior art keywords
derivatives
oxooxazolidinil
etenilbenceno
aminometil
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88117304T
Other languages
English (en)
Inventor
David Ross Brittelli
Walter Adelman Gregory
Peter Franklin Corless
Chung-Ho Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of ES2059467T3 publication Critical patent/ES2059467T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

DERIVADOS DEL ETEMILBENCENO OXOOXAZOLIDIMIL AMINOMETIL, INCLUYENDO LOS NITRILOS, SULFOXIDOS, ACETAMIDAS Y NITROCOMPUESTOS, TALES COMO L-N-[3-[4-(E-1-METIL-2-CIANOETENIL)FENIL]-2-OXOOZAHIDIN-5-ILMETIL]ACETAMIDA POSEEN UNA UTIL ACTIVIDAD ANTIBACTERIAL.
ES88117304T 1987-10-21 1988-10-18 Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos. Expired - Lifetime ES2059467T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11083787A 1987-10-21 1987-10-21

Publications (1)

Publication Number Publication Date
ES2059467T3 true ES2059467T3 (es) 1994-11-16

Family

ID=22335197

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88117304T Expired - Lifetime ES2059467T3 (es) 1987-10-21 1988-10-18 Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos.

Country Status (18)

Country Link
EP (1) EP0316594B1 (es)
JP (1) JPH01135777A (es)
KR (1) KR890006603A (es)
AT (1) ATE95176T1 (es)
AU (1) AU617697B2 (es)
CA (1) CA1317594C (es)
DE (1) DE3884563T2 (es)
DK (1) DK584188A (es)
ES (1) ES2059467T3 (es)
FI (1) FI884849A (es)
HU (1) HU201915B (es)
IL (1) IL88107A (es)
MY (1) MY103433A (es)
NO (1) NO884676L (es)
NZ (1) NZ226631A (es)
PT (1) PT88811B (es)
RU (1) RU1801109C (es)
ZA (1) ZA887853B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032605A (en) * 1987-10-09 1991-07-16 Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
US5036093A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
DE69216251T2 (de) * 1991-11-01 1997-05-15 Pharmacia & Upjohn Co., Kalamazoo, Mich. Substituierte aryl- und heteroaryl-phenyloxazolidinone
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
ATE161833T1 (de) * 1992-12-08 1998-01-15 Upjohn Co Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel
TW299332B (es) * 1992-12-08 1997-03-01 Upjohn Co
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
DE69419523T2 (de) * 1993-11-22 1999-11-25 Pharmacia & Upjohn Co., Kalamazoo Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester
BR9509136A (pt) * 1994-10-26 1998-07-21 Upjohn Co Composto e uso do mesmo
DK0792273T3 (da) * 1994-11-15 2003-06-16 Upjohn Co Bicycliske oxazin- og thiazin-oxazolidinon-antibakterielle midler
KR100441334B1 (ko) * 1995-02-03 2004-10-20 파마시아 앤드 업존 캄파니 헤테로-방향족고리치환된페닐옥사졸리딘온항균제
ATE204874T1 (de) * 1995-05-11 2001-09-15 Upjohn Co Spirocyclische und bicyclische diazinyl- und carbazinyloxazolidinone
MX9703040A (es) * 1995-09-12 1997-07-31 Upjohn Co Antimicrobianos de feniloxazolidinona.
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
CA2262906C (en) 1996-08-12 2006-10-31 Celgene Corporation Novel immunotherapeutic agents and their use in the reduction of cytokine levels
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
IL136062A (en) * 1997-11-12 2004-02-08 Upjohn Co History of xahydro - 5-oxo- (1, 4 diazepine-1-yl) phenyl oxazolidinone and pharmaceutical preparations containing them
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
CN1288462A (zh) 1998-01-23 2001-03-21 法玛西雅厄普约翰美国公司 噁唑烷酮组合库、组合物和制备方法
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
CA2374383A1 (en) * 1999-07-28 2001-02-08 Pharmacia & Upjohn Company Oxazolidinones and their use as antiinfectives
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
WO2002018354A1 (en) * 2000-08-31 2002-03-07 Abbott Laboratories Oxazolidinones and their use as antibacterial agents
WO2002020515A1 (en) * 2000-09-08 2002-03-14 Abbott Laboratories Oxazolidinone antibacterial agents
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US7125568B2 (en) 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
AU2004218364A1 (en) 2003-03-05 2004-09-16 Celgene Corporation Diphenylethylene compounds and uses thereof
US7470723B2 (en) 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
AU2005282727A1 (en) 2004-09-03 2006-03-16 Celgene Corporation Substituted heterocyclic compounds and uses thereof
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
PT1934208E (pt) 2005-10-04 2011-06-01 Bayer Schering Pharma Ag Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida
NZ587096A (en) 2008-03-26 2011-11-25 Global Alliance For Tb Drug Dev Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
EP3498273A1 (en) * 2017-12-14 2019-06-19 Universität Wien Pharmaceutical composition for modulating the response of a gaba-a receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
ES8506659A1 (es) * 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
CA1260948A (en) * 1984-12-05 1989-09-26 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents

Also Published As

Publication number Publication date
NO884676D0 (no) 1988-10-20
FI884849A0 (fi) 1988-10-20
RU1801109C (ru) 1993-03-07
IL88107A0 (en) 1989-06-30
IL88107A (en) 1993-02-21
KR890006603A (ko) 1989-06-14
ATE95176T1 (de) 1993-10-15
NO884676L (no) 1989-04-24
DE3884563D1 (de) 1993-11-04
EP0316594B1 (en) 1993-09-29
NZ226631A (en) 1991-01-29
DK584188A (da) 1989-04-22
ZA887853B (en) 1990-06-27
CA1317594C (en) 1993-05-11
MY103433A (en) 1993-06-30
AU617697B2 (en) 1991-12-05
HU201915B (en) 1991-01-28
FI884849A (fi) 1989-04-22
HUT52075A (en) 1990-06-28
EP0316594A1 (en) 1989-05-24
PT88811B (pt) 1993-04-30
DE3884563T2 (de) 1994-02-17
AU2404388A (en) 1989-04-27
DK584188D0 (da) 1988-10-20
JPH01135777A (ja) 1989-05-29

Similar Documents

Publication Publication Date Title
ES2059467T3 (es) Derivados de aminometil-oxooxazolidinil-etenilbenceno utiles como agentes antibacterianos.
ES2033394T3 (es) Derivados de aminometil-oxooxazolidinil-aroilbeceno utiles como agentes antibacterianos.
DE3584427D1 (de) Aminomethyl-, n-phenyl-substituierte oxooxazolidin derivate nuetzlich als antibakterielle mittel.
IT1212143B (it) Composizione ad attivita'tricogena.
DE69033952D1 (de) Antibakterielle Cephalosporin-Derivate
KR890701578A (ko) 신규의 티오펜 화합물 및 그들의 제법
SU1538480A1 (ru) 2-(α-Гидрокси-α-карбометокситрифторэтил)-тиофены, проявляющие антимикробную активность
ATE44642T1 (de) Synergetische herbizide mischungen und ihre verwendung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 316594

Country of ref document: ES